SCHEMBL6714895

SCHEMBL6714895

CCOC(=O)C(Cc1ccc(OCCNC(=O)c2ccc(-c3ccccn3)cc2)cc1)Oc1ccc(OC)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.49
EPHX2 P34913 1/20 0.46
KMT2A Q03164 2/20 0.46
PPARG P37231 1/20 0.45
RAB9A P51151 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
TP53 P04637 2/20 0.44
MAPK14 Q16539 1/20 0.43
SMO Q99835 1/20 0.43
MEN1 O00255 1/20 0.43
KDM1A O60341 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
MAPT P10636 1/20 0.43
TGFBR1 P36897 1/20 0.42
HPGD P15428 2/20 0.42
RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6712846 0.97 PPARG (0.47) NPC1KMT2APPARGRAB9ASMN1; SMN2
SCHEMBL6717755 0.95 NPC1 (0.48) NPC1KMT2APPARGRAB9ASMN1; SMN2
SCHEMBL6715973 0.94 NPC1 (0.51) NPC1KMT2APPARGRAB9ASMN1; SMN2
SCHEMBL6716164 0.93 PPARG (0.45) NPC1EPHX2KMT2APPARGRAB9A
SCHEMBL6718245 0.93 NPC1 (0.50) NPC1EPHX2KMT2APPARGRAB9A
SCHEMBL6716228 0.92 RAB9A (0.52) NPC1EPHX2KMT2APPARGRAB9A
SCHEMBL6713405 0.92 GCG (0.44) NPC1KMT2APPARGRAB9ASMN1; SMN2
SCHEMBL6717835 0.91 PPARG (0.43) NPC1KMT2APPARGRAB9ASMN1; SMN2
SCHEMBL6715781 0.91 TRPV1 (0.46) NPC1EPHX2PPARGRAB9ASMN1; SMN2
SCHEMBL6722372 0.91 PPARG (0.52) NPC1KMT2APPARGRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 NPC1 812/4885EPHX2 3288/4885KMT2A 3611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.